ESR2 and breast carcinoma: In addition to classical nuclear ERα (ESR1) and ERβ (ESR2) acting as ligand-activated transcription factors, it has become evident that non-nuclear ERs govern numerous cell processes in the brain and exert beneficial cardiometabolic effects without uterine or breast cancer growth in mammals.